Concepedia

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

Simon Heller, John B. Buse, Miles Fisher, Satish K. Garg, Michel Marre, Ludwig Merker, Éric Renard, David Russell‐Jones, Areti Philotheou, Ann Marie Ocampo Francisco,

The Lancet · 2012 · 401 citations · 18 references

Concepts

MedicineEndocrinologyPharmacologyClinical NutritionDiabetologyDiabetes ControlDiabetes ManagementDiabetes MellitusDiabetes PharmacotherapyGlycemic ControlInsulin TherapyBasal Insulin TherapyBasal RegimensBolus Insulin TherapyBolus RegimensInsulin ManagementInsulin MetabolismLong-acting Insulin Analogues

References

18

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

New England Journal of Medicine · 1993 · 24.7K citations · Full text

Medicine, Endocrinology, Internal Medicine +14

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

New England Journal of Medicine · 2005 · 5.1K citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

David M. Nathan, John B. Buse, Mayer B. Davidson et al. · Diabetes Care · 2008 · 3.8K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Standards of Medical Care in Diabetes—2011

Diabetes Care · 2010 · 2.9K citations · Full text

Medicine, Endocrinology, Internal Medicine +17

DECLARATION OF HELSINKI.

Bryan Gandevia, Ann Tovell · PubMed · 1964 · 2.1K citations